Search results for "ambulatory care"

showing 10 items of 119 documents

Outcome comparison of integrated psycho‐oncological care versus unstructured care—Results of a non‐randomised open‐label two‐arm trial

2019

Objective To compare patients' experiences with a systematic, integrated psycho-oncological care (IC) model to experiences with "care as usual" (CAU). Methods To improve patients' knowledge about psychosocial support options and to facilitate use, an IC model was developed by psycho-oncologists and a health insurance company and implemented in one German cancer care facility. Using a parallel, non-randomised design, these patients' experiences were compared to CAU patients. In 2015, both patient groups received questionnaires 6-12 months post-inpatient treatment. Main outcomes were awareness, use and opinion of psycho-oncological care (PC) and anxiety level (Generalized Anxiety Disorder Sca…

AdultMaleHealth Knowledge Attitudes Practicemedicine.medical_specialtyPsycho-OncologyAnxietyYoung Adult03 medical and health sciences0302 clinical medicineAmbulatory careGermanyNeoplasmsSurveys and QuestionnairesmedicineHealth insuranceHumansGeneralized Anxiety Disorder ScaleAgedAged 80 and overResponse rate (survey)business.industryMiddle AgedPatient Acceptance of Health CareMental healthCare facilityOncology030220 oncology & carcinogenesisPhysical therapyAnxietyFemaleOpen labelmedicine.symptombusinessDelivery of Health CareEuropean Journal of Cancer Care
researchProduct

Safety and efficacy of outpatient treatment with CPT-11 plus bolus folinic acid/5-fluorouracil as first-line chemotherapy for metastatic colorectal c…

2003

The combination of irinotecan (CPT-11), bolus 5-fluorouracil (5-FU) and folinic acid (FA) (Saltz regimen) has recently been questioned as first-line chemotherapy for metastatic colorectal cancer after high early death rates due to gastrointestinal and thromboembolic events were reported in two US trials. Therefore, we carefully evaluated the safety and efficacy of this regimen, with high value placed on the management of delayed diarrhea. Forty-six patients with metastatic colorectal cancer received this first-line treatment in nine German outpatient clinics. Dose reductions were mandatory from the first cycle in case of toxicity grade2. Chemotherapy was administered only to diarrhea-free p…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyColorectal cancermedicine.medical_treatmentLeucovorinEarly deathIrinotecanFolinic acidBolus (medicine)Internal medicineAntineoplastic Combined Chemotherapy ProtocolsAmbulatory CaremedicineHumansPharmacology (medical)Prospective StudiesAgedPharmacologyChemotherapybusiness.industryLiver NeoplasmsMiddle Agedmedicine.diseasedigestive system diseasesSurgerySurvival RateIrinotecanOncologyFluorouracilCamptothecinFemaleFluorouracilFirst line chemotherapyColorectal Neoplasmsbusinessmedicine.drugAnti-Cancer Drugs
researchProduct

The Objective and Subjective Caregiving Burden and Caregiving Behaviours of Parents of Adolescents with Anorexia Nervosa

2015

Objective: The study aimed to examine caregiving burden and levels of distress, accommodating behaviours, expressed emotion (EE) and carers' skills, in parents of adolescents with anorexia nervosa. Method: A semi-structured interview assessed the objective burden (time spent across caregiving tasks) in parents (n = 196) of adolescents (n = 144) receiving outpatient treatment for anorexia nervosa. Subjective burden (carers' distress), accommodating behaviours, EE and carers' skills were measured by self-report. Results: Mothers, on average, spent 2.5 h/day of care, mainly providing food and emotional support, compared with 1 h/day by fathers. The level of distress and accommodating behaviour…

AdultMaleParentsParenting/psychologyAdolescentAnorexia Nervosa/psychologycaregiving burdenMothersStressbehavioral disciplines and activitiesanorexia nervosaPsychological/psychologyCaregivers/psychologySurveys and Questionnairesmental disordersAmbulatory CareHumansParent-Child RelationsMaternal BehaviorPaternal Behavioraccommodating and enabling behaviourParentingDepressionMiddle AgedExpressed EmotionClinical PsychologyCaregiversPsychiatry and Mental Healthexpressed emotionFemalecarer skillDepression/psychologyStress PsychologicalParents/psychology
researchProduct

Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neur…

2020

Introduction The organization of the healthcare system has significantly changed after the recent COVID-19 outbreak, with a negative impact on the management of oncological patients. The present survey reports data collected by the Italian Association for Neuroendocrine Tumors on the management of patients with neuroendocrine neoplasia (NEN) during the pandemic dissemination. Methods A survey with 57 questions was sent to NEN-dedicated Italian centers regarding the management of patients in the period March 9, 2020, to May 9, 2020 Results The main modification in the centers’ activity consisted of decreases in newly diagnosed NEN patients (− 76.8%), decreases in performed surgical procedure…

AdultMalePediatricsmedicine.medical_specialtyEndocrinology Diabetes and MetabolismAntineoplastic Agents030209 endocrinology & metabolismNeuroendocrine tumorsMedical OncologyNO03 medical and health sciencesPatient safety0302 clinical medicineEndocrinologyAmbulatory careNeuroendocrine tumorSurveys and QuestionnairesEpidemiologyPandemicHumansMedicineLS4_3PandemicsPatient Care TeamPandemicbusiness.industryCOVID-19Multidisciplinary teamContinuity of Patient Caremedicine.diseaseManagementClinical trialItalyCOVID-19; management; multidisciplinary team; neuroendocrine tumors; pandemic; peptide receptors radionuclide therapy; SARS-CoV2030220 oncology & carcinogenesisRadionuclide therapySARS-CoV2s COVID-19 SARS-CoV2 Pandemic Neuroendocrine tumors Multidisciplinary team Management Peptide receptors radionuclide therapyPeptide receptors radionuclide therapyOriginal ArticleFemaleneuroendocrine tumorsbusinessHealth care quality
researchProduct

Efficacy of Therapeutic Intervention in Headache Units in Patients With Frequent Headaches: The EFUNCE Study

2006

Data confirming that therapeutic intervention in headache units is superior to care received by patients in other levels of the health system are scant. This is a pilot study that includes patients seen in 4 headache units for at least 1 year, who had a headache frequency of more than 15 days per month. The results of the first 30 patients showed a significant improvement in different headache parameters and a high degree of satisfaction with the treatment received.

AdultMalePediatricsmedicine.medical_specialtyQuality Assurance Health CarePilot ProjectsAmbulatory Care FacilitiesPatient satisfactionFrequent headachesQuality of lifeIntervention (counseling)HumansMedicineIn patientRetrospective Studiesbusiness.industryHeadacheRetrospective cohort studyMiddle AgedNeurologyPatient SatisfactionQuality of LifePhysical therapyMedicineFemaleNeurology (clinical)businessProgram EvaluationSpecializationHeadache: The Journal of Head and Face Pain
researchProduct

Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany

2012

Thomas Glaab1,2, Claus Vogelmeier3, Andreas Hellmann4, Roland Buhl11Department of Respiratory Diseases III, Medical Center of the Johannes Gutenberg-University, Mainz, 2Medical Affairs Germany, Respiratory Medicine, Boehringer Ingelheim Pharma GmbH and Co, KG, Ingelheim, 3Department of Respiratory Diseases, University Hospitals of Giessen and Marburg, Marburg, 4Federal Association of Pneumologists, Augsburg, GermanyBackground: Little is known about the role of guidelines for the practical management of chronic obstructive pulmonary disease (COPD) by office-based pulmonary specialists. The aim of this study was to assess their outpatient management in relation to current guideline recommenda…

AdultMaleSpirometryHealth Knowledge Attitudes Practicemedicine.medical_specialtyChronic bronchitisAttitude of Health Personneldiagnosismedicine.medical_treatmentInternational Journal of Chronic Obstructive Pulmonary DiseasePulmonary Disease Chronic ObstructivePatient Education as TopicAmbulatory careRisk FactorsGermanySurveys and QuestionnairesHealth careAmbulatory CaremedicineHumanssurveyPulmonary rehabilitationGOLDPractice Patterns Physicians'Referral and ConsultationOriginal ResearchtherapyCOPDEvidence-Based Medicinemedicine.diagnostic_testbusiness.industryGeneral MedicineGuidelineMiddle Agedmedicine.diseasepulmonary rehabilitationclinical outcomesObstructive lung diseaseRespiratory Function TestsBenchmarkingCross-Sectional StudiesHealth Care SurveysFamily medicinePractice Guidelines as TopicFemaleGuideline AdherencebusinessInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

ReMindCare App for Early Psychosis: Pragmatic Real World Intervention and Usability Study

2020

[EN] Background: eHealth interventions are widely used in clinical trials and increasingly in care settings as well; however, their efficacy in real-world contexts remains unknown. ReMindCare is a smartphone app that has been systematically implemented in a first episode of psychosis program (FEPP) for patients with early psychosis since 2018. Objective: The objective of this study was to assess the efficacy of ReMindCare after 19 months of use in the clinic and varying use by individual patients. Methods: The integration of the ReMindCare app into the FEPP started in October 2018. Patients with early psychosis self-selected to the app (ReMindCare group) or treatment as usual (TAU group). T…

AdultMaleTelemedicine020205 medical informaticsEuropean Regional Development FundHealth Informatics02 engineering and technologyClinical practiceReal-world intervention03 medical and health sciences0302 clinical medicineNursingIntervention (counseling)Political science0202 electrical engineering electronic engineering information engineeringAmbulatory CareCIENCIAS DE LA COMPUTACION E INTELIGENCIA ARTIFICIALmedia_common.cataloged_instanceHumansPsiquiatriaEuropean unionSalut mentalmedia_commonOriginal Paperbusiness.industryEarly psychosisUsabilityPsychosisMental healthMobile ApplicationsTelemedicine030227 psychiatryClinical PracticePsychotic DisordersFemaleMental healthSmartphonebusinessApp
researchProduct

A double-blind study comparing paroxetine and maprotiline in depressed outpatients.

1997

A double-blind multicenter randomized parallel group study comparing paroxetine and maprotiline was carried out in a total of 544 outpatients. Included were patients with varying degrees of severity of depressive symptoms who fulfilled modified RDC criteria for either Minor or Major Depression and showed a HAMD-17 score of > or = 13. No concomitant benzodiazepine treatment was allowed. Duration of treatment was 6 weeks, after an initial wash-out period. Doses were fixed during the first 3 weeks of treatment, patients receiving either 20 mg paroxetine or 100 mg maprotiline daily. An option for dose escalation was provided for insufficient responders after 3 weeks. The weekly assessments comp…

AdultMalemedicine.drug_classDouble-Blind MethodAnticholinergicAmbulatory CareMedicineHumansPharmacology (medical)Adverse effectMaprotilinePsychiatric Status Rating ScalesBenzodiazepineDepressive Disorderbusiness.industryGeneral MedicineParoxetinePsychiatry and Mental healthParoxetineMaprotilineConcomitantAnesthesiaAntidepressantAntidepressive Agents Second-GenerationFemalebusinessReuptake inhibitormedicine.drugPharmacopsychiatry
researchProduct

Quality of life in melanoma patients during adjuvant treatment with pegylated interferon-α2b: patients’ and doctors’ views

2011

Treatment of malignant melanoma with IFN-α has been associated with significant side-effects. The aim of this retrospective monocentric non-randomized study was first to evaluate the impact on quality of life (QOL) in 30 melanoma patients treated with once weekly 2 μg/kg PEG-IFN-α2b for 18 months, and second to examine whether there is a difference in patients' and physicians' perception of QOL. Data on QOL were collected by means of the EORTC QLQ-C30 questionnaire completed by the patient before consultation at baseline and every three months during treatment. A second questionnaire was filled out independently by the physician, based on the consultation and patient file. All data were rou…

AdultMalemedicine.medical_specialtyAdolescentEvery Three Monthsmedicine.medical_treatmentOnce weeklyDermatologyInterferon alpha-2Antiviral AgentsPolyethylene GlycolsYoung AdultAmbulatory careQuality of lifePegylated interferonHumansMedicineIn patientMelanomaAgedRetrospective StudiesAged 80 and overbusiness.industryMelanomaInterferon-alphaMiddle Agedmedicine.diseaseRecombinant ProteinshumanitiesChemotherapy AdjuvantQuality of LifePhysical therapyFemalebusinessAdjuvantmedicine.drugEuropean Journal of Dermatology
researchProduct

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depressi…

2003

OBJECTIVE Current clinical knowledge holds that antidepressants have a delayed onset of efficacy. However, the delayed onset hypothesis has been questioned recently by survival analytical approaches. We aimed to test whether early improvement under antidepressant treatment is a clinically useful predictor of later stable response and remission. METHOD We analyzed data from a randomized double-blind controlled trial with mirtazapine and paroxetine in patients with major depression (DSM-IV). Improvement was defined as a 17-item Hamilton Rating Scale for Depression (HAM-D-17) score reduction of > or = 20%. Stable response was defined as > or = 50% HAM-D-17 score reduction at week 4 and week 6,…

AdultMalemedicine.medical_specialtyAdolescentMirtazapineMirtazapineMianserinAntidepressive Agents TricyclicDrug Administration Schedulelaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineAmbulatory CareHumansPsychiatrySurvival analysisDepression (differential diagnoses)AgedPsychiatric Status Rating ScalesDepressive DisorderHamilton Rating Scale for DepressionMiddle AgedPrognosisParoxetineSurvival AnalysisClinical trialPsychiatry and Mental healthParoxetineTreatment OutcomeAntidepressantDrug Therapy CombinationFemalePsychologySelective Serotonin Reuptake Inhibitorsmedicine.drug
researchProduct